CUSIP: G23549101
Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
55,813,953
-
Total 13F shares
-
1,621,133
-
Share change
-
+1,621,133
-
Total reported value
-
$2,443,403
-
Price per share
-
$1.48
-
Number of holders
-
15
-
Value change
-
+$2,443,403
-
Number of buys
-
15
Quarterly Holders Quick Answers
What is CUSIP G23549101?
CUSIP G23549101 identifies CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP G23549101:
Institutional Holders of Connect Biopharma Holdings Ltd - Ordinary Shares (CNTB) as of Q3 2025
As of 30 Sep 2025,
Connect Biopharma Holdings Ltd - Ordinary Shares (CNTB) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,621,133 shares.
The largest 10 holders included
BML Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, MARSHALL WACE, LLP, Koa Wealth Management, LLC, XTX Topco Ltd, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MONOGRAPH WEALTH ADVISORS, LLC, HRT FINANCIAL LP, and CITIGROUP INC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.